Homopurine sequences of duplex DNA are binding sites for triplex-forming oligodeoxyribopyrimidines. The interactions of synthetic duplex DNA targets with an oligodeoxyribopyrimidine containing N 4 -(6-amino-2-pyridinyl)deoxycytidine (1), a nucleoside designed to interact with a single C·G base pair interruption of the purine target tract, was studied by UV melting, circular dichroism spectroscopy and dimethylsulfate alkylation experiments. Nucleoside 1 supports stable triplex formation at pH 7.0 with formation of a 1·Y·Z triad, where Y·Z is a base pair in the homopurine tract of the target. Selective interaction was observed when Y·Z was C·G, although A·T and, to a lesser extent, T·A and G·C base pairs were also recognized. The circular dichroism spectra of the triplex having a 1·C·G triad were similar to those of a triplex having a C + ·G·C triad, suggesting that the overall structures of the two triplexes are quite similar. Removal of the 6-amino group from 1 essentially eliminated triplex formation. Reaction of a triplex having the 1·C·G triad with dimethylsulfate resulted in a 50% reduction of methylation of the G residue of this triad. In contrast, the G of a similar triplex containing a U·C·G triad was not protected from methylation by dimethylsulfate. These results are consistent with a binding mode in which the 6-amino-2-pyridinyl group of 1 spans the major groove of the target duplex at the 1·C·G binding site and forms a hydrogen bond with the O6 of G. An additional stabilizing hydrogen bond could form between the N4 of the imino tautomer of 1 and the N4 amino group of C.
INTRODUCTION
Oligodeoxyribonucleotides can interact with double-stranded DNA to form triple-stranded complexes. There is considerable interest in the structure of these triplexes and in the possibility of using triplex-forming oligonucleotides as novel reagents to control gene expression (1) . Currently, sequence recognition of DNA by triplex-forming oligonucleotides is limited to interactions between oligopyrimidines or oligopurines and homopurine tracts within the DNA target. Although purine sequences of considerable length are frequently found in human and eukaryotic genes (2, 3) , these sequences are often interrupted by one or a few pyrimidine bases. Such py·pu base pair interruptions essentially act as mismatches and reduce the stability of the triplex or prevent triplex formation altogether (4) (5) (6) (7) (8) (9) (10) . The range of sequences recognized by triplex-forming oligonucleotides could be expanded considerably if means could be found to deal with these interruptions.
Various strategies have been developed to accommodate isolated py·pu interruptions of purine tracts. One approach is to simply skip the interruption. However, incorporation of an abasic site into an oligopyrimidine at a site opposite a single py·pu interruption resulted in considerable destabilization of the triplex (11) . Apparently, maintenance of continuous stacking interactions along the third strand is an important contributor to triplex stability.
Natural nucleic acid bases can interact with a py·pu interruption. Thus guanine can interact with a T·A base pair to form a G·T·A triad (6, 8, 12) and thymine can form a T·C·G triad (6) (7) (8) (9) (10) . Both the G·T·A and T·C·G triads involve the formation of a single hydrogen bond between the third strand base and the pyrimidine interruption (13) (14) (15) . This and distortions of the triplex at the site of the G·T·A or T·C·G triad may account for the generally observed reduced stability of triplexes involving these base triads.
Nucleoside analogs have also been shown to interact with C·G interruptions.When incorporated into an oligopurine, 2′-deoxynebularine interacts selectively with C·G and A·T base pairs in a purine·purine·pyrimidine triplex motif (16) . Similar recognition was observed for 5-fluoro-2′-deoxyuridine, an analog of thymidine (17) . The N-7-benzoyl derivative of 2′-deoxyformycin A was also found to allow triplex formation involving C·G interruptions (18) .
Non-natural nucleosides which recognize py·pu interruptions have been synthesized. Thus 1-(2-deoxy-β-D-ribofuranosyl)-4-(3-benzamidophenyl)imidazole when incorporated into an oligopyrimidine specifically recognizes T·A and C·G interruptions (19) . This nucleoside was found to interact by sequence-specific intercalation, rather than by hydrogen bonding to the base pair interruption (20) . Azole-2′-deoxyribonucleosides incorporated into triplex-forming oligopurines allow formation of triplexes with duplex targets containing T·A or C·G interruptions (21, 22) . The manner in which these nucleosides interact with the interruption remains to be characterized. Recently, 2-methyl-8-(N′-n-butylureido)naphth [1,2-d] imidazole was shown to hydrogen bond to a C·G base pair in chloroform solution (23) .
We have reported in a preliminary communication that an oligopyrimidine containing N 4 -(6-amino-2-pyridinyl)deoxycytidine Nucleic Acids Research, 1996 , Vol. 24, No. 13 2607 forms a triplex with a duplex target containing a single C·G interruption (24) . In this report we describe the syntheses of oligonucleotides containing this and other N 4 -(aryl)deoxycytidine derivatives and studies which further characterize triplex formation by these oligonucleotides.
MATERIALS AND METHODS
Reagent grade chemicals were used unless otherwise noted. HPLC grade acetonitrile was dried over calcium hydride. Anhydrous pyridine and methylene chloride were from Aldrich Chemical Co. Inc. Protected nucleoside 3′-(2-cyanoethyl-N,Ndiisopropylphosphoramidites) and nucleoside-derivatized controlled pore glass supports were from Glen Research. Flash chromatography was carried out using EM Science Kieselgel 60 (230-400 mesh). Thin layer chromatography (TLC) was performed on EM Reagents silica gel plates (0.2 mm). Analytical and preparative reversed phase HPLC were carried out on 4.6 × 150 mm and 10 × 250 mm Microsorb 5 µm C-18 columns (Rainin Instrument Co.) respectively at flow rates of 1.0 or 2.0 ml/min. Proton NMR spectra were recorded on a Brucker AMX 300 spectrometer. Chemical shifts are reported in p.p.m. Mass spectra were obtained using electron ionization (EI) or fast atom bombardment (FAB) techniques. Circular dichroism spectra were recorded on an Aviv circular dichroism spectropolarimeter fitted with a thermostatted cell compartment.
3′,5′-Di-O-acetyl-4-(1,2,4-triazol-1-yl)-2′-deoxyuridine (4)
A rapidly stirred suspension of 8.4 g 1,2,4-triazole in 120 ml dry acetonitrile was treated at 0_C by slow addition of 2.4 ml phosphorus oxychloride followed by dropwise addition of 18 ml triethylamine. The suspension was left stirring for 30 min and a solution of 936 mg 3′,5′-di-O-acetyl-2′-deoxyuridine (25) in 15 ml dry acetonitrile was added over a period of 20 min. Stirring was continued for 1.5 h until TLC showed no starting material remained. The reaction was stopped by addition of 150 ml saturated sodium bicarbonate. The aqueous solution was extracted with methylene chloride and the methylene chloride was removed by rotatory evaporation. The product, which was crystallized from ethyl acetate, was obtained in 73% yield as 800 mg of a pale yellow solid. Silica gel TLC R f : 0.25, ethyl acetate/hexane (3:1 v/v). 1 
3′,5′-Di-O-acetyl-N 4 -(6-amino-2-pyridinyl)-2′-deoxycytidine (5a)
A solution of 804 mg, 1 mmol, nucleoside 4 and 804 mg, 8 mmol, 2,6-diaminopyridine in 10 ml dry pyridine was refluxed for 3 days. TLC showed that no starting material remained. Pyridine was removed by evaporation, the residue was extracted into methylene chloride and the organic layer was washed with water. The methylene chloride was evaporated and the residue was subjected to silica gel flash chromatography using chloroform/methanol (10:1 v/v) as solvent. Nucleoside 5a was obtained in 53% yield as a pale yellow glassy solid. Silica gel TLC R f : 0. 22 Sixty milligrams, 0.15 mmol, nucleoside 5a was dissolved in 6 ml water/methanol (1:1 v/v) solution containing 0.2 N sodium hydroxide. The solution was stirred at room temperature for 20 min and was then neutralized by addition of 6 N hydrochloric acid at 0_C. The solvents were removed and the residue was taken up in methanol. The resulting precipitate was removed by filtration and the filtrate was evaporated. The residue was subjected to silica gel column chromatography using chloroform/methanol (3:1 v/v) as solvent. A solution of 200 mg, 0.5 mmol, nucleoside 5a in 5 ml dry pyridine was treated by dropwise addition of 0.17 ml, 1.5 mmol, benzoyl chloride at 0_C. The solution was stirred at room temperature for 2.5 h. Saturated sodium bicarbonate was added at 0_C, the solution was extracted with methylene chloride and the organic layer was washed with water. The organic layer was evaporated and the residue was washed with ethanol. Nucleoside 5b was obtained in 71% yield as a white precipitate. Silica gel TLC R f : 0.33, ethyl acetate/hexane (5:1 v/v). 1 
5′-O-Dimethoxytrityl-N 4 -(6-benzamido-2-pyridinyl)-2′-deoxycytidine (6b)
A solution of 80 mg, 0.19 mmol, nucleoside 6a in 2 ml dry pyridine was treated with 80 mg dimethoxytrityl chloride and 3 mg 4-N,N-dimethylaminopyridine for 2 h at room temperature. A 0.5 ml aliquot of methanol was added and stirring was continued for 20 min. The solvents were evaporated, the residue was dissolved in methylene chloride and the solution was extracted with water. The organic layer was evaporated and the residue subjected to silica gel column chromatography using a solvent which contained 5% triethylamine in ethyl acetate/methanol (15:1 v/v). The product, 6b, was obtained in 72% yield as a white glassy solid. Silica gel TLC R f : 0.38, 5% triethylamine in ethyl acetate/methanol (15:1 v/v). 1 
5′-O-Dimethoxytrityl-N 4 -(6-benzamido-2-pyridinyl)-2′-deoxycytidine-3′-O-(2-cyanoethyl-N,N-diisopropylaminophosphoramidite) (7a)
Nucleoside 6b was dried under vacuum for 48 h in the presence of phosphorous pentoxide. Eighty milligrams 6a were dissolved in a solution containing 1 ml dry methylene chloride and 0.061 ml dry triethylamine. The stirred solution was treated by dropwise addition of 0.037 ml N,N-bis-(diisopropylamino)-2-cyanoethoxyphosphine and stirring was continued for 15 min. Methanol was added and stirring was continued for an additional 10 min. The solution was diluted with ethyl acetate and then washed several times with saturated sodium bicarbonate. The organic layer was evaporated and the residue was subjected to silica gel column chromatography using ethyl acetate/methylene chloride/triethylamine ( 
N 4 -(3-Aminophenyl)-2′-deoxycytidine (2)
A solution of 726 mg nucleoside 4 and 1.7 g 1,3-phenylenediamine in 20 ml dry pyridine was refluxed for 4 h. The solvents were evaporated, the residue was dissolved in methylene chloride and the solution was washed with water. The organic layer was evaporated and the residue was subjected to silica gel column chromatography using chloroform/methanol (20: A 70 mg portion of the nucleoside was dissolved in 10 ml of a solution containing 0.2 N sodium hydroxide in methanol/water (1:1 v/v). The solution was stirred at room temperature for 20 min and then neutralized by addition of 6 N hydrochloric acid at 0_C. The solvents were evaporated, the residue was taken up in methanol and the resulting precipitate was removed by filtration. The filtrate was evaporated and the residue was subjected to silica gel column chromatography using chloroform/methanol (6:1 v/v) as solvent. The product, 2, was obtained as a white solid. Silica gel TLC R f : 0.30, chloroform/methanol (5:1 v/v). Reversed phase HPLC retention time, 18.4 min using a gradient of 2-3% acetonitrile, 0-12 min, and 3-30% acetonitrile in 50 mM sodium phosphate buffer, pH 5.8. 1 
N 4 -(2-Pyridinyl)-2′-deoxycytidine (3)
A solution of 726 mg nucleoside 4 and 1.4 g 2-aminopyridine in 20 ml dry pyridine was refluxed for 6 days. The solvents were evaporated, the residue was dissolved in methylene chloride and the organic solution was washed with water. The organic layer was evaporated and the residue subjected to silica gel column chromatography using chloroform/methanol (20:1 v/v) as solvent. A 420 mg portion of the nucleoside was dissolved in 50 ml of a solution containing 0.2 N sodium hydroxide in methanol/water (1:1 v/v). The solution was stirred at room temperature for 20 min and then neutralized by addition of 6 N hydrochloric acid at 0_C. The solvents were evaporated, the residue was taken up in methanol and the resulting precipitate was removed by filtration. The filtrate was evaporated and the residue was subjected to silica gel column chromatography using chloroform/methanol (6:1 v/v) as solvent. The product, 3, was obtained as a white solid. Silica gel TLC R f : 0.25, chloroform/methanol (6:1 v/v). Reversed phase HPLC retention time, 18.6 min using a gradient of 2-3% acetonitrile, 0-12 min, and 3-30% acetonitrile in 50 mM sodium phosphate buffer, pH 5.8. 1 
Syntheses of oligodeoxyribonucleotides
These were synthesized on an Applied Biosystems Model 392 DNA/RNA synthesizer using standard phosphoramidite chemistry (26) . The 5′-terminal dimethoxytrityl group was removed from the support-bound protected oligomer by the synthesizer. The oligomers were cleaved from the support and deprotected by treating the controlled pore glass support with a solution containing concentrated ammonium hydroxide/pyridine (1:1 v/v) at 55_C for 6 h. In the case of oligomers containing N 4 -(6-amino-2-pyridinyl)-2′-deoxycytidine, treatment was extended to 18 h to ensure complete removal of the 6-benzamido protecting group from this nucleoside. Deprotected oligomers were purified by preparative C-18 reversed phase HPLC using a 40 ml linear gradient of 5-15% acetonitrile in 50 mM sodium phosphate, pH 5.8. The column was operated at a flow rate of 2.0 ml/min and was monitored at 280 nm. Oligomers were desalted on C-18 SEP PAK cartridges (Water Associates) or on a small Microsorb (Rainin Instruments) C-18 reversed phase HPLC guard column cartridge. The oligomers gave the expected products after digestion to their component nucleosides using a combination of snake venom phosphodiesterase and bacterial alkaline phosphatase. Their extinction coefficients were determined as previously described (27) . 
Melting experiments
These were carried out in a buffer containing 50 mM 3-(N-morpholino)propanesulfonic acid, 0.1 M NaCl with or without 20 mM MgCl 2 . Triplexes were formed by adding 0.5 ml of a 2 µM solution of the third strand oligomer to 0.5 ml of a 2 µM solution of the preformed DNA duplex at room temperature and the solutions were incubated overnight at 4_C. Absorbance vs temperature profiles were recorded using a Cary 3E UV/vis spectrophotometer fitted with a thermostatted cell block connected to a temperature controller. The oligomer solutions were transferred to the sample cuvettes at 0_C and the cuvettes were bathed in dry nitrogen gas to prevent condensation at low temperature. The temperature was increased at a rate of 0.5_C/min.
Dimethylsulfate alkylation experiments
Solutions containing 1.8 µM [ 32 P]IV and 2.2 µM V or 2.2 µM IV and 1.8 µM [ 32 P]V in 50 mM MOPS, pH 7.0, 20 mM MgCl 2 , 0.1 M NaCl were prepared. A 5 µl aliquot of the preformed duplex, which contained 12 000 d.p.m. of 32 P-labeled oligonucleotide, was mixed with a 5 µl aliquot of buffer or buffer containing 2, 10 or 20 µM I at room temperature. These solutions were incubated overnight at 4_C. The solutions were then incubated for 30 min at 0_C. Each solution was treated with 1 µl dimethylsulfate for 3 min at 0_C. The reaction was quenched by addition of 2 µl 2-mercaptoethanol. Each solution was diluted with 3 µl 3 M NaOAc, 10 µg in 1 µl salmon sperm DNA and 100 µl ethanol. The solutions were placed on dry ice for 1 h and then centrifuged at 4_C at 16 000 r.p.m. for 20 min. The supernatant was removed and the precipitate was washed with 100 µl 90% ethanol. The pellet was dried under vacuum, dissolved in 50 µl 1 M aqueous piperidine and the solution was incubated at 90_C for 30 min. The solvent was removed by evaporation and the residue was evaporated once with 20 µl 50% acetonitrile/water. The residue was then dissolved in 10 µl 90% formamide loading buffer. The solution was heated for 1 min at 90_C, loaded onto a 40 cm, 20% denaturing polyacrylamide gel and the samples were electrophoresed at 800 V. The gels were dried and subjected to autoradiography at -80_C and were also scanned by a phosphorimager.
RESULTS

Syntheses of triplex-forming oligonucleotides
Triplex formation was studied in the intermolecular systems I·II·III(X·Y·Z) and I·IV·V(X·Y·Z), shown in Figure 1 . The duplex targets contained the four possible Watson-Crick base pairs at position Y·Z. The third strand oligopyrimidine I(X), whose backbone is parallel to the purine-rich strands of the duplexes, contained two 5-methyldeoxycytidines (C) and either N 4 -(6-amino-2-pyridinyl)deoxycytidine (1) , N 4 -(3-aminophenyl)deoxycytidine (2) or N 4 -(2-pyridinyl)deoxycytidine (3) at position X.
The deoxycytidine derivatives were prepared as outlined in Figure 2 and described in Materials and Methods. The oligomers used the corresponding phosphoramidites following standard procedures. 
Triplex melting experiments
With the exceptions noted below, the A 260 vs tempeature profiles of triplex I·II·III(X·Y·Z) and triplex I·IV·V(X·Y·Z) showed two sigmoidal transitions corresponding first to dissociation of the third strand and second dissociation of the duplex. Only small linear increases in absorbance were seen when the individual strands of these triplexes were heated, suggesting that these strands do not undergo self-interactions (data not shown). The melting temperatures at pH 7.0 for dissociation of oligomer I(X) from these triplexes are shown in Table 1 and 2. Oligomer I(1) interacted to various extents with all eight duplex targets. The most stable triplexes were formed with duplex targets which contained C·G or A·T base pairs at position Y·Z.
As shown in Figure 3 , triplex I·II·III(1·C·G) melted in a unique manner. When the triplex was heated at a rate of 0.5_C/min, two transitions corresponding to dissociation of I(1) from target duplex II·III(C·G) were observed with T m values of 25 and 38_C. These transitions occured prior to dissociation of the target duplex, whose T m is 48_C. Only a single transition was seen at 25_C when the sample was cooled. When the sample was heated at a slower rate, 0.2_C/min, a single broad transition was observed whose inflection point is 28_C. Prolonged incubation of I·II·III(1·C·G) at 4_C prior to melting resulted predominantly in the appearance of the transition at 38_C.
Similar behavior was observed for oligomer I(2), which contains N 4 -(3-aminophenyl)-deoxycytidine. Again, selective triplex formation was observed with targets containing C·G or A·T base pairs at position Y·Z and the melting temperatures observed for the dissociation of I(2) were similar to those observed for I(1). As in the case of I(1), two transitions are observed for the dissociation of I(2) from duplex II·III(C·G).
In contrast to the biphasic transition observed with I·II·III(1·C·G), a single transition was observed for the dissociation of I(1) from triplex I·IV·V(1·C·G). The melting profiles of this triplex and that of I·IV·V(U·C·G) are shown in Figure 4 .
Removal of the 6-amino group from nucleoside 1 had a significant destabilizing effect on triplex formation or resulted in the loss of triplex formation altogether. Thus oligomer I(3), which contains N 4 -(2-pyridinyl)deoxycytidine, did not form triplexes with II·III(A·T), II·III(G·C) or IV·V(C·G). This oligomer did appear to interact with II·III(T·A) and II·III(C·G), although only the upper part of the transition curve could be observed and the T m values for these transitions were estimated to be v5_C.
Dimethylsulfate alkylation of I·IV·V(X·C·G)
Reactions of duplex IV·V with dimethylsulfate in the presence of increasing concentrations of I(1) or I(U) were carried out at 0_C. This temperature is well below the T m values for the dissociation of the third strands of these triplexes. Autoradiograms of the gels from reactions run in the presence of I(U) or I(1) are shown in Figure 5A and B respectively. The topmost band observed in these gels is undissociated duplex IV·V. Lanes 1-4 of Figure 5A show that G19 of the upper strand of the duplex (strand IV) was protected from methylation by I(U). Protection was almost complete at a 1:1 stoichiometry of I(U) to duplex. This result is consistent with formation of a triplex between I(U) and the duplex target. Although G16 is also part of the binding site for 
I(U)
, it was not protected by the oligomer. In addition, G31 and G32, which are located outside the oligomer binding site, appeared to be hypermethylated. Similar hypermethylation of guanines outside a triplex binding site has been observed in other systems (28) . No decrease in methylation is observed for G20 of the lower strand (strand V), even in the presence of a 10-fold excess of I(U), as shown in lanes 5-8.
When I(1) was used as the third strand in these experiments, G19 of strand IV was again protected from methylation, as shown in Figure 5B , lanes 1-4. This result demonstrates that a triplex was formed between I(1) and IV·V under the conditions of the experiment. The pattern of methylation of the other guanines of strand IV was essentially identical to those observed when I(U) was used as the third strand oligomer. In contrast to the results obtained in the presence of I(U), G20 of strand V was partially protected from methylation by I(1). Quantitation of the G20 band in lanes 5-6 by phosphorimaging showed that methylation decreased ∼50% in the presence of 1, 5 and 10 µM I(1) relative to methylation seen in the absence of I(1).
DISCUSSION
The pyrimidine base of a py·pu interruption provides only one site for hydrogen bond formation with a base of a triplex-forming oligonucleotide. Base analogs which can potentially form hydrogen bonds with both bases of the py·pu base pair might enhance triplex stability and/or specificity at the site of interruption. Previously, we showed that oligomer I(X), where X is N 4 -(3-acetamidopropyl)deoxycytidine, formed a stable, but rather weak, triplex with II·III(C·G) (29) . The flexible acetamidopropyl arm of this deoxycytidine derivative is sufficiently long to span the major groove of the duplex and potentially hydrogen bond to the guanine base of the C·G base pair.
N 4 -(6-Amino-2-pyridinyl)deoxycytidine (1) has a more rigid arm and two potential hydrogen bonding sites for interaction with a C·G base pair (24) . Molecular models indicate that the pyridine ring of 1 is capable of spanning the major groove of the target duplex. As shown in Figure 6 , this would place the 6-amino group of 1 within hydrogen bonding proximity to the O6 or N7 of G. Formation of the imino tautomer of 1 would allow additional hydrogen bonding between the N4 of 1 and the N 4 -amino group of the C·G base pair. In addition to providing a rigid platform to position the hydrogen bonding groups, the planar aromatic ring of 1 could also participate in stabilizing stacking interactions with bases neighboring 1. Alternatively, the pyridine ring of I could intercalate into the duplex in a manner analogous to the binding mode of 1-(2-deoxy-β-D-ribofuranosyl)-4-(3-benzamidophenyl) imidazole (D 3 ) (20) .
The UV spectrum of 1 has two absorption maxima at 284 and 323 nm at pH 6.5. These maxima appear at wavelengths longer than those observed for the absorption maxima of deoxycytidine (270 nm) and diaminopyridine (308 nm). The observed red shifts of these two maxima suggest conjugation between the two heterocyclic rings of the nucleoside, which could arise as a consequence of tautomerization. The observation that the absorption maxima of O 4 -(3-aminophenyl)-2′-deoxyuridine, which cannot tautomerize, are not red shifted relative to the absorption maxima of deoxyuridine or 3-aminophenol is consistent with this suggestion.
The proton NMR spectrum of 1 shows temperature-dependent broadening of the H5 proton of the cytosine ring and the H3 proton of the pyridine ring (24) . These resonances both sharpen to doublets when the temperature is raised to 67_C, behavior which suggests restricted rotation about the C4-N4 bond of the nucleoside. Similar temperature-dependent broadenings were also observed for the cytosine H5 protons of N 4 -(3-aminophenyl) deoxycytidine (2) and N 4 -(2-pyridinyl)deoxycytidine (3), but not for O 4 -(3-aminophenyl)deoxyuridine or O 4 -(2-pyridinyl)deoxyuridine, analogs of 2 and 3 in which an oxygen replaces the exocyclic nitrogen at the 4 position of the pyrimidine ring.
Oligonucleotide I(1) forms a stable triplex with duplex target II·III(C·G) at neutral pH ( Table 1 ). The unusual biphasic transition which is observed prior to melting of the duplex target (Fig. 3) suggests the formation of two distinct triplexes between oligomer I(1) and II·III(C·G). When the triplex is heated at a rate of 0.2_C/min, a single broad transition replaces the biphasic transition seen when the triplex is heated at 0.5_C/min. In addition, prolonged incubation of I·II·III(1·C·G) at 4_C prior to melting shifts dissociation of I(1) predominantly to the higher temperature, as monitored by the relative change in hypochromicity of the transition. Thus the two triplexes appear to be interconvertable. The transition seen at 38_C corresponds to melting of the more thermodynamically stable triplex and that seen at 25_C to the less stable triplex. The latter triplex is initially formed when the three strands are cooled at 0.5_C/min and the less stable triplex converts to the more stable triplex upon prolonged incubation at 4_C. Similar melting behavior is seen with I·II·III(2·C·G), which suggests that this phenomena is not unique to the pyridinyl ring. The formation of two triplexes suggests that 1 or 2 can bind by two distinct modes. Thus the bases could interact by intercalation as well as by hydrogen bonding.
The formation of two types of triplexes appears to be unique to the interactions between I(1) or I(2) and duplex target II·III(C·G). Thus only a single melting transition was observed for the third strand dissociation of triplex I·IV·V(1·C·G). Target IV·V(C·G) consists of 45 bp, whereas II·III(C·G) contains 15 bp, which is the same length as oligomer I(1). When I(1) interacts with IV·V(C·G), the resulting triplex is flanked on either side by a 15mer duplex. The presence of these flanking duplexes may impose limitations on the conformational flexibility of the triplex and thus restrict the interaction of I(1) to the formation of a single type of triplex. Such conformational restrictions may be absent when I(1) interacts with II·III(C·G) to form triplex I·II·III(1·C·G), which lacks flanking duplex regions.
Despite the unusual melting behavior of I·II·III(1·C·G), the circular dichroism spectum (data not shown) of this triplex at 10_C is almost identical to previously studied triplexes, I·II·III(X·G·C), where X is 2′-deoxycytidine or 8-oxo-2′-deoxyadenosine (27) . The circular dichroism spectrum of I·II·III(1·C·G) is thus characteristic of triplexes having mostly T·A·T triads (30) . This suggests that the presence of the 1·C·G triad in either binding mode does not lead to significant structural distortions of the triplex.
The T m values for the third strand dissociations of I·II·III(1·C·G) and I·IV·V(1·C·G) compare favorably with those of corresponding triplexes which contain C + ·G·C triads at positions X·Y·Z (Tables 1 and 2 ). Oligomer I(1) also forms stable triplexes, I·II·III(1·A·T) and I·IV·V(1·A·T), in which A·T occupies position Y·Z of the duplex target. The stabilities of these triplexes are somewhat greater than that of triplex I·II·III(T·A·T), which contains a T·A·T triad at position X·Y·Z. The A·T base pair presents hydrogen bonding sites similar to those of the C·G base pair. Consequently, N 4 -(6-amino-2-pyridinyl)deoxycytidine could interact with A·T in a manner similar to that proposed for its interaction with C·G, as shown in Figure 6 . An additional hydrogen bond may be formed with the N7 of A and such formation could account for the greater stability of I·II·III(1·A·T) than of I·II·III(T·A·T).
The 6-amino group of 1 plays an essential role in the interactions between oligomer I(1) and target duplexes II·III(Y·Z) and IV·V(C·G). Thus, replacement of the 6-amino-2-pyridinyl group of 1 with a 2-pyridinyl group essentially eliminates interaction between I(3) and its targets. This result is consistent with the hydrogen bonding schemes proposed for the formation of the 1·C·G and 1·A·T triads. Formation of the imino tautomeric form of 1, which provides a hydrogen bond acceptor site for the N 4 -H of C·G and the N 6 -H of A·T may be facilitated by the ability of the 6-amino group of 1 to interact with O6 of G or the O4 of T of these base pairs. Alternatively, the 6-amino group of 1 may participate in hydrogen bonding interactions with the base neighboring the Y·Z site. Such interactions may contribute to formation of less stable triplexes when T·A and G·C occupy the Y·Z position of a target duplex.
Further insight into the interaction between 1 and the C·G base pair was obtained from experiments in which triplexes I·IV·V(U·C·G) and I·IV·V(1·C·G) were probed with dimethylsulfate. Previous experiments showed that deoxyuridine can form a stable U·C·G triad (10) and the third strand dissociation of I·IV·V(U·C·G) has a T m of 14_C ( Table 2 ). Protection of G19 of strand V was observed when I·IV·V(U·C·G) was treated with dimethylsulfate ( Fig. 5A ), but no protection of G20 of strand V was seen. This is expected, because only a single hydrogen bond is formed between deoxyuridine and deoxycytidine when a U·C·G triad is formed (15) . This is because deoxyuridine is located on the side of the major groove nearest strand IV, where the N7 of G20 of strand V is exposed and available for reaction with dimethylsulfate.
When I·IV·V(1·C·G) reacts with dimethylsulfate, protection of G19 of strand IV is again observed, consistent with triplex formation. Based on the similarity of the methylation patterns of I·IV·V(U·C·G) and I·IV·V(1·C·G), the overall structures of these two triplexes appear to be similar, if not identical. A significant difference is seen, however, for G20 of strand V, which is partially protected from methylation. This result is consistent with the proposed hydrogen bonding scheme shown in Figure 6 . By spanning the major groove, the 6-aminopyridinyl ring restricts access of dimethylsulfate to the N7 of G20. Because methylation of G20 is not completely blocked, it is unlikely that the 6-amino group of I(1) hydrogen bonds to the N7 of G20.
Oligonucleotide I(1) preferentially forms a triplex with duplex targets containing a C·G interruption, although less stable triplexes are also observed when other base pairs are present at this position. This behavior is in contrast to that observed when N 4 -(3-acetamidopropyl)-2′-deoxycytidine is located at position X of oligomer I (29) . In that case the oligomer interacts only with target II·III(Y·Z), which contains a C·G interruption, although the stability of this triplex is less than that of the one formed by oligomer I(1). The ability of I(1) to form triplexes with targets having different base pairs may be due in part to stabilizing base stacking interactions between the aromatic pyridinyl ring and neighboring bases of the oligomer when it forms a triplex. Such stacking interactions are unlikely to occur in oligomers which contain N 4 -(3-acetamidopropyl)deoxycytidine. The ability to stack and the potential for 1 to exist in multiple tautomeric forms may account for the reduced sequence specificity of 1 versus N 4 -(3-acetamidopropyl)deoxycytidine.
Our results show that N 4 -(6-amino-2-pyridinyl)deoxycytidine may be used to address single C·G interruptions of a homopurine tract in duplex DNA targets. Nucleoside derivatives of this type may thus be used to extend the range of sequences recognized by triplex-forming oligonucleotides. This ability may prove useful in the design of novel antigene oligonucleotides.
